Skip to main content

Search

Reset all filters
263 Result(s)
Sort by

More health in vulnerable communities

More health in vulnerable communities

Making More Health, offers expertise, network and financial support to social entrepreneurs, plus more. Read more about Making More Health here.
COVID-Relief-India-2021

COVID-Relief-India-2021

Boehringer Ingelheim prioritises life continuity to the underserved, in addition to medical aid. Click here to find out and learn more information.
COVID-19: Research Update

COVID-19: Research Update

Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
Stem cells a new frontier

Stem cells a new frontier

Stem cells may be a game changer for the development of new veterinary treatments. Click here to read this story and find out more information.
pet care digital age

pet care digital age

Pets can be family members, trusted companions – and they are also part of a large global industry. Learn more about pet care in the digital age here.
Metabolic Diseases

Metabolic Diseases

Interconnected cardio-renal-metabolic conditions – affecting the heart, kidneys, and metabolic system – are the leading cause of mortality worldwide.
Poultry

Poultry

We are proud to play a critical role in feeding the world with safe, affordable, abundant and sustainable quality poultry meat and eggs. Learn more here.
Sites Around the World

Sites Around the World

Find out about Boehringer Ingelheim's sites around the world. With 52,000 employees worldwide, we have sites in Ingelheim, Germany to Yamagata, Japan.
COVID-19 Joining forces against COVID-19

COVID-19 Joining forces against COVID-19

While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
COVID-19 Boehringer Ingelheim Clinical Trials

COVID-19 Boehringer Ingelheim Clinical Trials

We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
Say no to the uninvited guests

Say no to the uninvited guests

Boehringer Ingelheim aims to raise awareness of the issues & risks that parasites can have on cats. Click here to find out more information.
Interview: Excellence in stem cell treatments

Interview: Excellence in stem cell treatments

Acquisition of GST reflects the enormous potential of biotechnology research to provide breakthrough therapies for major diseases. Learn more.
10 years of Making More Health

10 years of Making More Health

10 years ago, Boehringer Ingelheim started the social initiative Making More Health together with our partner Ashoka. Watch the video here to learn more.
Poultry Innovation Days 2018

Poultry Innovation Days 2018

As a global leader in poultry disease prevention, Boehringer Ingelheim gathered more than 500 leaders in the global poultry industry in Prague. Learn more.
One step further in fighting rabies in Vietnam

One step further in fighting rabies in Vietnam

A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages. Find out more.ral villages.
COVID-19 In Colombia we support integrally

COVID-19 In Colombia we support integrally

At Boehringer Ingelheim Colombia, we are caring for those in the most vulnerable situations during COVID-19. Click here to learn more about our work.
COVID-19 PetPro Connect

COVID-19 PetPro Connect

Our PetPro Connect platform connects veterinarians and pet owners and makes it easy to deliver the collaborative pet care experience pet owners seek.
COVID-19 Volunteering in India

COVID-19 Volunteering in India

Learn about our employees in India volunteering during COVID-19, including Rashmi Suvarna, Head of Procurement at Boehringer Ingelheim India.
COVID-19 IMI2–Call 21

COVID-19 IMI2–Call 21

CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.